MedPath

The effect of mindfulness therapy on psychological problems of patients with gastrointestinal cancers

Not Applicable
Recruiting
Conditions
Condition 1: gastric cancer. Condition 2: Colon Cancer.
Malignant neoplasm of stomach
Malignant neoplasm of colon
Registration Number
IRCT20200211046458N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Age over 20 years and under 65 years
Have a minimum education in reading and writing in order to answer the questionnaires
Definitive diagnosis of one of the stomach or intestinal cancers
Simultaneous administration of chemotherapy
moderate depression and anxiety scores
Do not participate in any yoga and meditation classes in the last 6 months
Willingness to complete intervention sessions
Physical ability to attend 45-minute sessions

Exclusion Criteria

Existence of a severe mental illness (presence of any period of mania or hypomania, psychotic disorder and substance use disorders)
comorbid of a severe physical illness (other than gastrointestinal cancers)
Consumption of psychiatric drugs
Receive any other type of psychotherapy at the same time
Occurrence of an important stressful event in life (such as the death of a loved one) during treatment
Two recurrent absences in treatment sessions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of Life. Timepoint: Before the intervention, after the intervention (60days after the first evaluation), 60 days after the intervention. Method of measurement: Quality of Life Questionnaire (EOROTC QLQ-C30).;Pain. Timepoint: Before the intervention, after the intervention (60 days after the first evaluation), 60 days after the intervention. Method of measurement: West Hawn-Yale Multidimensional Pain Questionnaire.;Psychological problems (depression, anxiety and stress). Timepoint: Before the intervention, after the intervention (60 days after the first evaluation), 60 days after the intervention. Method of measurement: Depression, Anxiety, and Stress Scale (DASS-21).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath